Literature DB >> 24077862

Patient classification and hospital reimbursement for inguinal hernia repair: a comparison across 11 European countries.

L Serdén, J O'Reilly.   

Abstract

PURPOSE: This comparative study examines the categorisation of patients undergoing surgical repair of inguinal hernia in the diagnosis-related group (DRG) systems of 11 European countries (Austria, England, Estonia, Finland, France, Germany, Ireland, the Netherlands, Poland, Spain and Sweden). Understanding the design and operation of DRG systems for this common surgical procedure is important, given their increasing use internationally for hospital reimbursement and performance measurement.
METHODS: A common definition was used to identify inguinal hernia patients and the corresponding data were extracted from national databases. The analysis compared the variables and algorithms for classifying these patients to DRGs across the participating countries, as well as the number, composition and relative resource intensity of groups. An index case and six standardised vignettes were grouped using each country’s DRG system and the associated quasi-prices were calculated.
RESULTS: The number of groups to which inguinal hernia patients are assigned is typically three or four, but ranges from two in Poland to ten in France. In most systems, categorising patients is contingent on procedure, principal and secondary diagnoses, and age, with treatment setting (day case/inpatient) being less common. Added to these, the French system also incorporates length of stay and whether the patient died. More resource intensive DRGs generally contained patients who were older, treated as inpatients, did not die, had (more severe) complications and/or co-morbidities, and/or underwent laparoscopic repair. There are cross-country disparities in day case rates and the use of laparoscopic repairs.
CONCLUSIONS: The categorisation of inguinal hernia patients varies across the 11 European DRG systems under study. By highlighting the main differences across these systems, this comparative analysis allows the relevant decision makers to assess the adequacy and specificity of their own DRG systems.

Entities:  

Mesh:

Year:  2014        PMID: 24077862     DOI: 10.1007/s10029-013-1158-8

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  13 in total

1.  Paying for hospital care: the experience with implementing activity-based funding in five European countries.

Authors:  Jacqueline O'Reilly; Reinhard Busse; Unto Häkkinen; Zeynep Or; Andrew Street; Miriam Wiley
Journal:  Health Econ Policy Law       Date:  2012-01

2.  Homogeneity of the German diagnosis-related groups.

Authors:  Jürgen Stausberg; Emanuel Kiefer
Journal:  Health Serv Manage Res       Date:  2010-11

3.  Activity based financing in England: the need for continual refinement of payment by results.

Authors:  Andrew Street; Alan Maynard
Journal:  Health Econ Policy Law       Date:  2007-10

4.  Performance of 10 European DRG systems in explaining variation in resource utilisation in inguinal hernia repair.

Authors:  Jacqueline O'Reilly; Lisbeth Serdén; Mats Talbäck; Brian McCarthy
Journal:  Health Econ       Date:  2012-08       Impact factor: 3.046

5.  How well do diagnosis-related groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data.

Authors:  Andrew Street; Conrad Kobel; Thomas Renaud; Josselin Thuilliez
Journal:  Health Econ       Date:  2012-08       Impact factor: 3.046

6.  Case mix definition by diagnosis-related groups.

Authors:  R B Fetter; Y Shin; J L Freeman; R F Averill; J D Thompson
Journal:  Med Care       Date:  1980-02       Impact factor: 2.983

Review 7.  Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.

Authors:  K McCormack; B Wake; J Perez; C Fraser; J Cook; E McIntosh; L Vale; A Grant
Journal:  Health Technol Assess       Date:  2005-04       Impact factor: 4.014

8.  European Hernia Society guidelines on the treatment of inguinal hernia in adult patients.

Authors:  M P Simons; T Aufenacker; M Bay-Nielsen; J L Bouillot; G Campanelli; J Conze; D de Lange; R Fortelny; T Heikkinen; A Kingsnorth; J Kukleta; S Morales-Conde; P Nordin; V Schumpelick; S Smedberg; M Smietanski; G Weber; M Miserez
Journal:  Hernia       Date:  2009-07-28       Impact factor: 4.739

9.  Case mix use in 25 countries: a migration success but international comparisons failure.

Authors:  Francis H Roger France
Journal:  Int J Med Inform       Date:  2003-07       Impact factor: 4.046

10.  Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries.

Authors:  Wilm Quentin; David Scheller-Kreinsen; Alexander Geissler; Reinhard Busse
Journal:  Langenbecks Arch Surg       Date:  2011-12-24       Impact factor: 3.445

View more
  4 in total

1.  Heterogeneity of European DRG systems and potentials for a common EuroDRG system Comment on "Cholecystectomy and Diagnosis-Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries".

Authors:  Alexander Geissler; Wilm Quentin; Reinhard Busse
Journal:  Int J Health Policy Manag       Date:  2015-03-05

2.  Reservations Regarding the Suitability of the DRG System.

Authors:  Kai Witzel; Ralph Lorenz
Journal:  Dtsch Arztebl Int       Date:  2016-04-08       Impact factor: 5.594

3.  Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database.

Authors:  Zuzana Špacírová; David Epstein; Jaime Espín
Journal:  Eur J Health Econ       Date:  2022-02-26

4.  Standardization of medical service indicators: A useful technique for hospital administration.

Authors:  Li Wu; Conghua Ji; Hanti Lu; Xuewen Hong; Shan Liu; Ying Zhang; Qiushuang Li; Sijia Huang; Penglei Zhou; Jiong Yao; Yuxiu Hu
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.